Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2020 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2020.0285
Abstract: Importance Female sex has been identified as a risk factor for bleeding after percutaneous coronary intervention (PCI) and may have contributed to the underuse of drug-eluting stents in women. This risk may be further enhanced… read more here.
Keywords: risk; high bleeding; trial; sex ... See more keywords
High bleeding risk patients
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30572
Abstract: Identification and management of patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI) have been of great interest in the last years, due to the higher incidence of adverse events in this population.… read more here.
Keywords: bleeding risk; high bleeding; hbr patients; non hbr ... See more keywords
TCT-539 Clinical outcomes in high bleeding risk patients undergoing complex PCI with the Xience everolimus eluting stent: a patient-level pooled analysis from four Xience post-approval trials
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.1723
Abstract: High bleeding risk (HBR) patients experience not only high risk for bleeding but also high risk for ischemic events. Similarly, complex vs. non-complex PCI is generally associated with increased ischemic risk. We aimed to evaluate… read more here.
Keywords: risk; high bleeding; xience; complex pci ... See more keywords
TCT-311 4-Year Clinical Outcomes in High Bleeding Risk Patients After Surgical or Percutaneous Left Main Coronary Artery Revascularization: The EXCEL Trial
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.08.388
Abstract: There is little data on long-term outcomes in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) for left main coronary artery disease. In the EXCEL trial, 1,905… read more here.
Keywords: left main; artery; high bleeding; coronary artery ... See more keywords
Tailoring duration of DAPT with risk scores
Sign Up to like & getrecommendations! Published in 2017 at "The Lancet"
DOI: 10.1016/s0140-6736(17)30591-3
Abstract: www.thelancet.com Vol 389 March 11, 2017 987 Dual antiplatelet therapy (DAPT) reduces stent thrombosis and ischaemic events after percutaneous coronary intervention (PCI), but increases the risk of bleeding. Current guidelines recommend default DAPT durations of… read more here.
Keywords: dapt; risk; high bleeding; duration dapt ... See more keywords
IMPACT OF DIABETES MELLITUS ON LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENT IN A HIGH-BLEEDING RISK POPULATION: OUTCOMES FROM THE POOLED XIENCE REGISTRY
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)31873-x
Abstract: The impact of diabetes mellitus (DM) in a high bleeding risk (HBR) population undergoing percutaneous coronary intervention (PCI) remains unclear. We sought to investigate 4-year outcomes after PCI with a Xience V stent in this… read more here.
Keywords: bleeding risk; high bleeding; coronary intervention; percutaneous coronary ... See more keywords
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial
Sign Up to like & getrecommendations! Published in 2022 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.121.011569
Abstract: Background: Patients at high-bleeding risk (HBR) undergoing percutaneous coronary intervention represent a challenging patient population. The use of drug-coated balloon (DCB) allows shorter duration of dual antiplatelet therapy compared with drug-eluting stents (DES) and reduces… read more here.
Keywords: bleeding risk; patients without; high bleeding; drug ... See more keywords
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the American Heart Association"
DOI: 10.1161/jaha.121.023454
Abstract: Background It is unknown whether contemporary drug-eluting stents have a similar safety profile in high bleeding risk patients treated with 1-month dual antiplatelet therapy following percutaneous coronary interventions. Methods and Results We performed an interventional,… read more here.
Keywords: bleeding risk; high bleeding; month; month dual ... See more keywords
Performance of the Academic Research Consortium High Bleeding Risk Criteria in Patients With ST-Segment Elevation Myocardial Infarction: A Single Center Study.
Sign Up to like & getrecommendations! Published in 2022 at "Angiology"
DOI: 10.1177/00033197221135739
Abstract: We assessed the ability of predicting mortality and total in-hospital bleeding and adverse outcomes by the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary… read more here.
Keywords: research consortium; academic research; consortium high; hospital bleeding ... See more keywords
A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.803233
Abstract: Objective To compare the clinical benefits of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation (NVAF) with high bleeding risk. Methods A retrospective study was conducted on patients with high bleeding risk NVAF who… read more here.
Keywords: group; bleeding risk; clinical benefits; rivaroxaban group ... See more keywords
Anticoagulation Management in High Bleeding-Risk ECMO in Adults
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.884063
Abstract: Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy that has increasingly been used in recent years for the treatment of severe respiratory failure or cardiogenic shock, in the venovenous (VV) or veno-arterial (VA) configuration, respectively… read more here.
Keywords: bleeding risk; anticoagulation management; bleeding; high bleeding ... See more keywords